Conditions: Attenuated Familial Adenomatous Polyposis; Familial Adenomatous Polyposis
Interventions: Drug: Erlotinib Hydrochloride; Other: Laboratory Biomarker Analysis
Sponsor: National Cancer Institute (NCI)
Not yet recruiting - verified November 2016
http://ift.tt/2f8LOkB
Αρχειοθήκη ιστολογίου
-
▼
2023
(256)
-
▼
Φεβρουαρίου
(140)
-
▼
Φεβ 19
(17)
- Implementable Deep Learning for Multi‐sequence Pro...
- An evaluation of mechanical and biophysical skin p...
- Multifunctional Two-Dimensional Bi2Se3 Nanodiscs f...
- An integrated strategy to identify COVID‐19 causal...
- Downregulation of miR‐193a/b‐3p during HPV‐induced...
- Monitoring of SARS‐CoV‐2 concentration and circula...
- Pustular psoriasis in Malaysia: A review of the Ma...
- The ability of magnetic resonance imaging to predi...
- Nuclear membrane irregularity in high‐grade urothe...
- Impact of Exercise and Detraining on Signs of Pube...
- LRRK2 Inhibition by BIIB122 in Healthy Participant...
- Spermidine reduced neuropathic pain in chronic con...
- Xenogeneic collagen matrix versus connective tissu...
- Tixagevimab/Cilgavimab Treatment and Cardiovascula...
- Recombinant measles virus encoding the spike prote...
- Characterization of protein-based risk signature t...
- Acute Posterior Multifocal Placoid Pigment Epithel...
-
▼
Φεβ 19
(17)
- ► Ιανουαρίου (116)
-
▼
Φεβρουαρίου
(140)
-
►
2022
(1695)
- ► Δεκεμβρίου (78)
- ► Σεπτεμβρίου (142)
- ► Φεβρουαρίου (155)
-
►
2021
(5507)
- ► Δεκεμβρίου (139)
- ► Σεπτεμβρίου (333)
- ► Φεβρουαρίου (628)
-
►
2020
(1810)
- ► Δεκεμβρίου (544)
- ► Σεπτεμβρίου (32)
- ► Φεβρουαρίου (28)
-
►
2019
(7684)
- ► Δεκεμβρίου (18)
- ► Σεπτεμβρίου (53)
- ► Φεβρουαρίου (2841)
- ► Ιανουαρίου (2803)
-
►
2018
(31838)
- ► Δεκεμβρίου (2810)
- ► Σεπτεμβρίου (2870)
- ► Φεβρουαρίου (2420)
- ► Ιανουαρίου (2395)
-
►
2017
(31987)
- ► Δεκεμβρίου (2460)
- ► Σεπτεμβρίου (2605)
- ► Φεβρουαρίου (2785)
- ► Ιανουαρίου (2830)
-
►
2016
(5308)
- ► Δεκεμβρίου (2118)
- ► Σεπτεμβρίου (877)
- ► Φεβρουαρίου (41)
- ► Ιανουαρίου (39)
Αλέξανδρος Γ. Σφακιανάκης
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5
Άγιος Νικόλαος Κρήτη 72100
2841026182
6032607174
Δευτέρα 14 Νοεμβρίου 2016
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
Durvalumab, an Anti-PD-L1 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer
Conditions: Esophageal Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma
Interventions: Biological: durvalumab; Drug: carboplatin AUC 2/paclitaxel; Radiation: External beam radiation; Procedure: esophagogastrectomy
Sponsors: Memorial Sloan Kettering Cancer Center; AstraZeneca
Recruiting - verified November 2016
http://ift.tt/2extqWn
Interventions: Biological: durvalumab; Drug: carboplatin AUC 2/paclitaxel; Radiation: External beam radiation; Procedure: esophagogastrectomy
Sponsors: Memorial Sloan Kettering Cancer Center; AstraZeneca
Recruiting - verified November 2016
http://ift.tt/2extqWn
Exercise Prior to Oesophagectomy
Conditions: Postoperative Complications (Cardiopulmonary); Oesophageal Adenocarcinoma
Interventions: Behavioral: Pre-operative Exercise Programme (my-PEP); Behavioral: Home Exercise Programme (HEP)
Sponsor: University of East Anglia
Recruiting - verified November 2016
http://ift.tt/2f8KbDB
Interventions: Behavioral: Pre-operative Exercise Programme (my-PEP); Behavioral: Home Exercise Programme (HEP)
Sponsor: University of East Anglia
Recruiting - verified November 2016
http://ift.tt/2f8KbDB
Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer
Condition: Recurrent or Metastatic Head and Neck Carcinoma
Interventions: Drug: vinflunine; Drug: Methotrexate
Sponsor: Pierre Fabre Medicament
Recruiting - verified November 2016
http://ift.tt/2exrc9m
Interventions: Drug: vinflunine; Drug: Methotrexate
Sponsor: Pierre Fabre Medicament
Recruiting - verified November 2016
http://ift.tt/2exrc9m
Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma
Conditions: Locally Advanced Basal Cell Carcinoma; Skin Cancer; Cutaneous Malignancy
Interventions: Drug: Vismodegib; Radiation: Radiation therapy
Sponsors: Sue Yom; Genentech, Inc.
Recruiting - verified November 2016
http://ift.tt/2f8KTRm
Interventions: Drug: Vismodegib; Radiation: Radiation therapy
Sponsors: Sue Yom; Genentech, Inc.
Recruiting - verified November 2016
http://ift.tt/2f8KTRm
The Buried Bumper Syndrome: External Bumper Extraction after Radial Mini Incisions and Replacement through an Adjacent Tract
Although considered as a safe method to provide long-term nutritional support, percutaneous endoscopic gastrostomy (PEG) may be complicated by a buried bumper syndrome (BBS), a life-threatening condition. Removal of the PEG tube with its buried bumper and reinsertion of a new PEG tube is often necessary. Since its description in 1988, less than 50 cases of BBS managed by external extraction of the buried bumper have been reported. We report a case of buried bumper that was removed by external traction without the need for endoscopic or laparoscopic treatment but with the need of two radial millimeter skin incisions after abdominal CT study and finally immediate PEG replacement but through an adjacent site.
http://ift.tt/2fRCUJZ
Three cases of herpetic folliculitis causes by varicella-zoster virus: Immunohistochemical analysis
http://ift.tt/2fyhHnq
Εγγραφή σε:
Αναρτήσεις (Atom)